Literature DB >> 19362700

Regulation of the cytosolic DNA-sensing system in innate immunity: a current view.

Hideyuki Yanai1, David Savitsky, Tomohiko Tamura, Tadatsugu Taniguchi.   

Abstract

The sensing of nucleic acids by pattern recognition receptors is a central feature of innate immunity and is mediated by two types of receptors, Toll-like receptors and cytosolic receptors. Indeed, DNA, be it pathogen-derived or self-derived, can potently trigger the innate immune system; and much attention has been focused on the regulation of the DNA-sensing system(s) in the context of protective and pathological immune responses. An accumulating body of evidence has demonstrated that in addition to the membrane-bound type DNA-sensing receptor TLR9, there are cytosolic DNA receptors that can also evoke these responses. In particular, DAI (DLM-1/ZBP1), Trex1, and other regulators of the cytosolic DNA-sensing system have recently been identified and characterized. Here, we summarize our current understanding of how cytosolic DNA receptors contribute to the regulation of innate immune responses and discuss the complexity of the cytosolic DNA-sensing system as well as its future prospects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362700     DOI: 10.1016/j.coi.2009.01.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  30 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 2.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells.

Authors:  Meaghan H Hancock; Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

4.  ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling.

Authors:  Linlin Gao; Helen Coope; Susan Grant; Averil Ma; Steven C Ley; Edward W Harhaj
Journal:  J Biol Chem       Date:  2011-09-01       Impact factor: 5.157

Review 5.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

6.  RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I interferon production.

Authors:  Jun Feng; Paul D De Jesus; Victoria Su; Stephanie Han; Danyang Gong; Nicholas C Wu; Yuan Tian; Xudong Li; Ting-Ting Wu; Sumit K Chanda; Ren Sun
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.

Authors:  Melanie R Neeland; Martin J Elhay; David R Powell; Fernando J Rossello; Els N T Meeusen; Michael J de Veer
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

8.  Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut.

Authors:  Natalia Shulzhenko; Andrey Morgun; William Hsiao; Michele Battle; Michael Yao; Oksana Gavrilova; Marlene Orandle; Lloyd Mayer; Andrew J Macpherson; Kathy D McCoy; Claire Fraser-Liggett; Polly Matzinger
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

9.  Comparative analysis of microbial sensing molecules in mucosal tissues with aging.

Authors:  O A Gonzalez; S Kirakodu; M J Novak; A J Stromberg; L Orraca; J Gonzalez-Martinez; A Burgos; J L Ebersole
Journal:  Immunobiology       Date:  2017-10-16       Impact factor: 3.144

10.  Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection.

Authors:  Jamel Mankouri; Rennos Fragkoudis; Kathryn H Richards; Laura F Wetherill; Mark Harris; Alain Kohl; Richard M Elliott; Andrew Macdonald
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.